Superior Mesenteric Artery Stenosis Diagnosis and Management

Pathophysiology and Clinical Presentation

The American College of Radiology states that SMA stenosis is a narrowing of the superior mesenteric artery, typically caused by atherosclerotic disease at the vessel origin, that reduces blood flow to the small intestine and proximal colon, leading to chronic mesenteric ischemia with characteristic postprandial abdominal pain 1
SMA stenosis is distinguished from SMA syndrome, with the latter being a mechanical compression of the duodenum between the SMA and aorta, typically affecting young, thin patients with weight loss 2
Atherosclerotic narrowing typically occurs at the ostial or proximal SMA origin where atherosclerotic plaques accumulate, and symptomatic SMA stenosis most often occurs when accompanied by celiac trunk occlusion, as collateral flow becomes insufficient 3
The mesenteric circulation has extensive collaterals, so isolated SMA stenosis may remain asymptomatic until severe, and the small intestine can compensate for 75% reduction in blood flow for up to 12 hours before ischemia develops 3
Postprandial abdominal pain is the hallmark symptom, occurring 15-60 minutes after eating due to increased intestinal metabolic demand that cannot be met by stenotic blood flow, and key clinical features include progressive weight loss from fear of eating and chronic symptoms developing over months 1

The American College of Radiology recommends CTA as the primary diagnostic modality to evaluate SMA stenosis and assess for multi-vessel involvement, and imaging findings include aortic atherosclerotic disease with SMA-origin stenosis, assessment of celiac artery and IMA patency, and evaluation for collateral vessel development 1
Angiography with percutaneous transluminal angioplasty and stent placement is rated as usually appropriate for symptomatic SMA stenosis with multi-vessel disease, with a rating of 8/9, and surgical bypass or endarterectomy is rated as usually appropriate when endovascular approach is not technically feasible, with a rating of 7/9 1
Systemic anticoagulation alone is rated as may be appropriate, with a rating of 5/9, and should be complementary to revascularization, not used as sole therapy, and medical management includes aggressive lipid lowering for atherosclerotic plaque stabilization, and anticoagulation prevents thrombotic progression but does not address the underlying stenosis 1

The most dangerous error is delaying diagnosis in patients with postprandial pain and weight loss, as progression can lead to acute-on-chronic mesenteric ischemia and bowel infarction, and additional pitfalls to avoid include confusing chronic mesenteric ischemia with SMA syndrome in young patients with weight loss, failing to evaluate for multi-vessel disease, and using anticoagulation as definitive therapy rather than as adjunct to revascularization 1, 2, 3
Early intervention prevents progression to acute mesenteric ischemia and bowel necrosis 3